Overview Profitable stocks in 2026 depend on strong company fundamentals and fair valuation in a high-volatility stock market ...

Metabolic health looks very different in 2026 than it did just a few years ago. Consumers are no longer chasing extreme fat burners, stimulant-heavy capsules, or aggressive appetite suppressants.

Everyone knows colorful mascaras have been on the rise over the past few years. That's no secret. Our makeup resolution for ...

Markiplier shows a lot of promise as a filmmaker with Iron Lung, but its sluggish pacing bogs it down a few notches.

Cullough of Wiley Rein LLP discuss the Department of Justice Criminal Division's Fraud Section year in review, including ...

In 2025, discovery became faster, more strategic, and more complex. From AI-driven review and hybrid workflows to expanding ...

What do latest US polls say about President Donald Trump's current approval rating? What polls say on Trump's job performance ...

Cobra's new 3D printed irons are an absolute thing of beauty that perform as well as they look. But will anyone be willing to ...

As aesthetic trends evolve, Simply Skin Medical Spa is meeting regional demand by expanding its operations to three locations: Clarion, Franklin, and its newest clinic in Robinson Town Center. The ...

Tripadvisor just released its annual trendcast report, exploring the themes predicted to dominate travel this year, based on ...

Appeals from indigent defendants have fallen precipitously in recent years. Experts aren’t sure what’s behind the "really ...

Ivonescimab is a first-in-class, investigational bispecific antibody targeting programmed cell death protein 1 and vascular endothelial growth factor.